Imported paracoccidioidomycosis in Spain.
The report deals with three patients, who developed paracoccidioidomycosis in Europe after having been in South America 50, 25 and 38 years before, respectively. The conditions for the long period of quiescent infection and for the late manifestations are discussed.
Ginarte
Manuel
M
Department of Dermatology, Faculty of Medicine, Complejo Hospitalario Universitario de Santiago, Santiago de Compostela, Spain. manuelpe@usc.es
Pereiro
Manuel
M
Toribio
Jaime
J
D000368:Aged; D000935:Antifungal Agents / Q000494:pharmacology / Q000627:therapeutic use; D015725:Fluconazole / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D017964:Itraconazole / Q000494:pharmacology / Q000627:therapeutic use; D008297:Male; D010228:Paracoccidioides / Q000166:cytology* / Q000254:growth & development; D010229:Paracoccidioidomycosis / Q000175:diagnosis / Q000382:microbiology* / Q000473:pathology* / Q000628:therapy; D013020:South America; D013030:Spain; D013997:Time Factors
D000935:Antifungal Agents; D017964:Itraconazole; D015725:Fluconazole